Makov: “Nothing in the world will stop generics”

Teva reports Q2 results showing $230 million profits, beating analyst projections. Shares suffer from recent sharp declines   Results for Israeli pharmaceutical Teva were pleasing, despite negative sentiment that hovered over its shares...

Antitrust director to force Dankner to sell telecommunications holdings

Demand is a condition for IDB acquisition of Bezeq. Strum: Dankner must resign from Cellcom Nochi Dankner will be required to sell his holdings in Barak, Netvision and Globecall before he can...

Ginko plans to raise NIS 130 million for oil exploration

Estimates Dead Sea reserves hold 20 billion barrels. Ginko Oil Exploration is planning to raise NIS 130 million on the Tel Aviv Stock Exchange at the end of the month to finance...

Car prices to drop 10% by 2006

Director of Customs and VAT Dept. Eitan Rov: Possible reduction in purchase tax on new cars to be explored. The current tax on private cars totals 95% of the price. Good news...

Bank of Israel sets optimistic forecast for 2005

Foresees growth of 3.5%, business output up 4.8% and unemployment down to 9.9%. Economic growth will reach 3.5% in 2005, business production will increase by 4.8% and standard of living (individual consumption)...

Teva’s Q2 profits increase by 9%

Profits totaling $230 million in the second quarter, despite recent negative trends in company's stock. Financial results of the Israeli medicine company were surprisingly positive during the second quarter despite recent negative...